These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21521860)

  • 21. Role of levetiracetam in the treatment of epilepsy.
    Brodie MJ; French JA
    Epileptic Disord; 2003 May; 5 Suppl 1():S65-72. PubMed ID: 12915344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
    Xiao Z; Li JM; Wang XF; Xiao F; Xi ZQ; Lv Y; Sun HB
    Eur Neurol; 2009; 61(4):233-9. PubMed ID: 19176965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased levetiracetam clearance and breakthrough seizure in a pregnant patient successfully handled by intensive therapeutic drug monitoring.
    Cappellari AM; Cattaneo D; Clementi E; Kustermann A
    Ther Drug Monit; 2015 Jun; 37(3):285-7. PubMed ID: 25384117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generic substitution of antiepileptic drugs.
    Sander JW; Ryvlin P; Stefan H; Booth DR; Bauer J
    Expert Rev Neurother; 2010 Dec; 10(12):1887-98. PubMed ID: 21091318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levetiracetam for seizures in children with brain tumors and other cancers.
    Partap S; Fisher PG
    Pediatr Blood Cancer; 2009 Feb; 52(2):288-9. PubMed ID: 18831033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generic substitution in the treatment of epilepsy: patient and physician perceptions.
    Berg MJ; Gross RA; Haskins LS; Zingaro WM; Tomaszewski KJ
    Epilepsy Behav; 2008 Nov; 13(4):693-9. PubMed ID: 18589000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study.
    Wheless JW; Clarke D; Hovinga CA; Ellis M; Durmeier M; McGregor A; Perkins F
    J Child Neurol; 2009 Aug; 24(8):946-51. PubMed ID: 19264738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy.
    Lancelin F; Franchon E; Kraoul L; Garciau I; Brovedani S; Tabaouti K; Landré E; Chassoux F; Paubel P; Piketty ML
    Ther Drug Monit; 2007 Oct; 29(5):576-83. PubMed ID: 17898647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levetiracetam.
    Beaulieu MJ
    Neonatal Netw; 2013; 32(4):285-8. PubMed ID: 23835548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switching from branded to generic antiepileptic drugs as a confounding factor and unpredictable diagnostic pitfall in epilepsy management.
    Di Bonaventura C; Fattouch J; Fabbrini G; Manfredi M; Prencipe M; Giallonardo TA
    Epileptic Disord; 2007 Dec; 9(4):465-6. PubMed ID: 18055310
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics of levetiracetam in neonates with seizures.
    Merhar SL; Schibler KR; Sherwin CM; Meinzen-Derr J; Shi J; Balmakund T; Vinks AA
    J Pediatr; 2011 Jul; 159(1):152-154.e3. PubMed ID: 21592494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous levetiracetam in the management of acute seizures in children.
    Reiter PD; Huff AD; Knupp KG; Valuck RJ
    Pediatr Neurol; 2010 Aug; 43(2):117-21. PubMed ID: 20610122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of Overnight Switch from Brand-Name to Generic Levetiracetam.
    Vari MS; Pinto F; Mencaroni E; Giudizioso G; Minetti C; La Neve A; Francavilla T; Piccioli M; Striano S; del Gaudio L; Tovo P; Striano P; Verrotti A
    Clin Drug Investig; 2016 Jan; 36(1):87-91. PubMed ID: 26507620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice.
    Donato Di Paola E; Gareri P; Davoli A; Gratteri S; Scicchitano F; Naccari C; De Sarro G
    Epilepsy Res; 2007 Jul; 75(2-3):112-21. PubMed ID: 17553669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S; Cao J; Xiao N; Cai F
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous levetiracetam in children with seizures: a prospective safety study.
    Ng YT; Hastriter EV; Cardenas JF; Khoury EM; Chapman KE
    J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accidental overdosage of levetiracetam in two children caused no side effects.
    Awaad Y
    Epilepsy Behav; 2007 Sep; 11(2):247. PubMed ID: 17692573
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of levetiracetam in special populations.
    French J
    Epilepsia; 2001; 42 Suppl 4():40-3. PubMed ID: 11564125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.